Development and validation of stability indicating method for determination of sertraline following ICH guidlines and its determination in pharmaceuticals and biological fluids

Table 4 Application of the proposed spectrofluorimetric method to the determination of SER in spiked human plasma.

Sample	Amount added (μg/mL)	Amount found (μg/mL)	% Recovery
1-Plasma (intra-day precision)
	0.2	0.209	104.50
	0.25	0.242	96.80
	0.30	0.295	98.33
	0.35	0.347	99.14
	0.40	0.407	101.75
Mean ± SD			100.10
			3.04
2-Plasma (inter-day precision)	0.30	0.270	90.00
	0.30	0.270	90.00
	0.30	0.280	93.33
Mean ± SD			91.11
			1.92